Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$98K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Novavax INC |
| AGRANT◆ |
| 14,180 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jun 18 | NVAX | Novavax INC | AGRANT◆ | 21,270 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | MXCT | Maxcyte, INC. | AGRANT◆ | 49,579 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | MXCT | Maxcyte, INC. | AGRANT | 30,421 | — | — | +13.2% | Open the original filing on SEC.gov |
| Jun 9 | ALDX | Aldeyra Therapeutics, Inc. | AGRANT◆ | 2,323 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | ALDX | Aldeyra Therapeutics, Inc. | AGRANT◆ | 19,909 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | ALDX | Aldeyra Therapeutics, Inc. | AGRANT◆ | 70,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ALDX | Aldeyra Therapeutics, Inc. | PBUY | 70,000 | $1.40 | $98K | +56.0% | Open the original filing on SEC.gov |